Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination
Background The antitumor effects of external beam radiation therapy (EBRT) are mediated, in part, by an immune response. We have reported that a single fraction of 12 Gy EBRT combined with intratumoral anti-GD2 hu14.18-IL2 immunocytokine (IC) generates an effective in situ vaccine (ISV) against GD2-...
Saved in:
Main Authors: | Zachary S Morris, Paul M Sondel, Amy K Erbe, Alexander L Rakhmilevich, Amber M Bates, Peter M Carlson, Alexander A Pieper, Ravi B Patel, Jen Birstler, Joseph Grudzinski, Reinier Hernandez, Bryan P Bednarz, Jamey P Weichert, Arika S Feils, Matthew Rodriquez, Claire Sun, Ian Marsh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e005463.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental-use Permits
by: Frederick M. Fishel
Published: (2005-09-01) -
Experimental-use Permits
by: Frederick M. Fishel
Published: (2005-09-01) -
Improving Environmental Permitting Systems: Integrated Permits in the Netherlands
by: Hanna Dürtge Tolsma
Published: (2014-10-01) -
INNOVATIVE PROCESSES IN AIC: PROBLEMS AND PERMITS
by: A. Kamalova, et al.
Published: (2016-10-01) -
Magnetic Nanoparticles with Core Shell: Macroscopic Model and Coercive Field
by: O. Hudak, et al.
Published: (2010-01-01)